Anne Berberich

N2M2 (NOA-20) phase I/II trial of molecularly matched targeted therapies plus radiotherapy in patients with newly diagnosed non-MGMT hypermethylated glioblastoma

Wolfgang Wick, Susan Dettmer, Anne Berberich et al. · Neuro-Oncology · 2018 · 145 citations · Full text

Medicine, Molecular Medicine, Oncology +17

Endovascular Versus Medical Management of Posterior Cerebral Artery Occlusion Stroke: The PLATO Study

Thanh N. Nguyen, Muhammad M. Qureshi, Davide Strambo et al. · Stroke · 2023 · 100 citations · Full text

Medicine, Neurology, Neurosurgery +12

Targeting Resistance against the MDM2 Inhibitor RG7388 in Glioblastoma Cells by the MEK Inhibitor Trametinib

Anne Berberich, Carina M. Thomé, Stefan Pusch et al. · Clinical Cancer Research · 2018 · 78 citations · Full text

Medicine, Oncology, Pharmacology +17

Dual Antiplatelet Therapy Improves Functional Outcome in Patients With Progressive Lacunar Strokes

Anne Berberich, Christine Schneider, Tilman Reiff et al. · Stroke · 2019 · 52 citations

Medicine, Neurology, Pharmacotherapy +17

Benefits of eculizumab in AQP4+ neuromyelitis optica spectrum disorder: Subgroup analyses of the randomized controlled phase 3 PREVENT trial

Jacqueline Palace, Dean M. Wingerchuk, Kazuo Fujihara et al. · Multiple Sclerosis and Related Disorders · 2020 · 40 citations · Full text

Life Sciences, Neurology, Pharmacotherapy +15